Dystonia: Clinical Trials

307 trials for Dystonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

175 completed, 47 recruiting, 36 unknown, 17 terminated. 93 Not applicable, 42 Phase 2, 20 Phase 3, 19 Phase 4, 18 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable93Completed 38, Recruiting 21, Unknown 13, Terminated 7, Withdrawn 4, Active not recruiting 3, Enrolling by invitation 3, Not yet recruiting 3, Suspended 1
Phase 242Completed 24, Recruiting 6, Unknown 6, Terminated 3, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 320Completed 16, Unknown 3, Withdrawn 1
Phase 419Completed 14, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Phase 118Completed 11, Unknown 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Early Phase 11Completed 1

Follow Dystonia: new trials by email Literature Review of Dystonia trials Research Report on Dystonia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Assessment of Cervical Range of Motion Restrictions in Infants With Arthrogenic Torticollis - A Feasibility Study
Mobilisation of the upper cervical spine (but the effectiveness of the investigation is not part of the study evaluation) - Torticollis (Arthrogenic)
Not yet recruitingBalgrist University Hospital102026-10-072026-10-08
DaxibotulinumtoxinA for Blepharospasm
Botulinum Neurotoxin Type A - Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid
Phase 2RecruitingUniversity of Pennsylvania202026-09-242026-09-29
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
DBS - Dystonia, Pediatric
Not applicableRecruitingChildren's Hospital Medical Center, Cincinnati752026-09-012026-10-20
Noninvasive Brain Stimulation for Cervical Dystonia
Active continuous theta-burst stimulation, Sham continuous theta-burst stimulation - Cervical Dystonia
Not applicableRecruitingFondazione Policlinico Universitario Campus Bio-Medico262026-07-062026-09-17
Zinc as an Adjunctive Therapy for Cervical Dystonia
Zinc citrate, Placebo - Cervical Dystonia
Phase 2RecruitingUniversity of Florida252026-06-012026-05-15
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia
Long-read whole genome sequencing - Dystonia, Movement Disorders
Not applicableRecruitingUniversity Hospital, Strasbourg, France1502026-04-222026-05-20
Impact of rTMS on Abnormal Cortical fMRI in Patients With Dystonia
Transcranial Magnetic Stimulation - Dystonia Disorder
Not applicableRecruitingNorthwell Health102026-03-042026-10-16
Validity and Reliability of the Hypertonia Assessment Tool (HAT) in Stroke Patients
Stroke, Hypertonia
Not yet recruitingFatih Sultan Mehmet Training and Research Hospital602026-03-012026-02-24
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
VIM0423, VIM0423 Placebo - Dystonia
Phase 2RecruitingVima Therapeutics1002026-02-052026-10-26
LIFUS For Neurological Disorders
LIFUS, Sham LIFUS - Parkinson's Disease (PD), Essential Tremor
Not applicableRecruitingUniversity Health Network, Toronto502025-12-022026-08-13
UltraSound-Guided Versus Non-Ultrasound-Guided Botulinum Toxin Injections in Cervical Dystonia [CUSTODY]
Ultrasound-guided botulinum toxin injection, Non-ultrasound-guided botulinum toxin injection - Idiopathic Cervical Dystonia
Not applicableRecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1002025-11-012026-02-13
Local Field Potentials in Dystonia
Deep Brain Stimulation System - Dystonia, Dystonia, Focal
RecruitingNewcastle-upon-Tyne Hospitals NHS Trust252025-09-042025-12-30
Predicting DBS Outcomes in Dystonia Using Wearable Gait Sensors
Wearable Gait Sensor Analysis - Dystonia
RecruitingRuijin Hospital502025-08-012026-01-07
Intraoperative Microelectrode Recordings Using MAVEN Compared to Standard Recording Apparatuses
Multifunctional Apparatus for Voltammetry, Electrophysiology, and Neuromodulation (MAVEN) - Essential Tremor, Parkinson's Disease
RecruitingMayo Clinic302025-07-292026-10-09
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Corabotase, Placebo - Cervical Dystonia
Phase 2RecruitingIpsen1322025-06-302026-09-08
An Observational Study of Individuals With Isolated Dystonia
Isolated/Primary Dystonia That Affects More Than One Region of the Body
Active not recruitingVima Therapeutics2002025-06-172026-09-21
Using Technology for Prediction and Prevention of Infant Torticollis and Plagiocephaly
in-app notification - Torticollis
Not applicableNot yet recruitingCollege of Staten Island, the City University of New York562025-06-012024-06-26
The Effects of Waning of Botulinum Toxin in the Treatment of Cervical Dystonia
Botulinum toxin type A injection - Cervical Dystonia, Primary
Phase 4Not yet recruitingWestern University, Canada452025-03-302025-03-20
Development in Children Diagnosed With Congenital Muscular Torticollis
Torticollis Congenital, Motor Development
CompletedGazi University402025-03-132025-06-25

Showing 20 of 307. Sign in to see all of them.

Narrower conditions

Torticollis (119)  ·  Parkinson Disease (61)  ·  Dystonic Disorders (48)  ·  Essential Tremor (37)  ·  Movement Disorders (31)  ·  Blepharospasm (20)  ·  Cerebral Palsy (20)  ·  Muscle Spasticity (16)  ·  Tremor (14)  ·  Dysphonia (12)  ·  Dystonia, Focal, Task-Specific (9)  ·  Ataxia (8)  ·  Parkinsonian Disorders (8)  ·  Chorea (7)

Broader conditions

Pathological Conditions, Signs and Symptoms (307)  ·  Signs and Symptoms (306)  ·  Neurologic Manifestations (303)  ·  Dyskinesias (300)  ·  Nervous System Diseases (209)  ·  Central Nervous System Diseases (139)  ·  Brain Diseases (96)  ·  Movement Disorders (91)  ·  Basal Ganglia Diseases (70)  ·  Neurodegenerative Diseases (66)  ·  Synucleinopathies (61)  ·  Parkinsonian Disorders (56)  ·  Eye Diseases (24)  ·  Mental Disorders (22)

Interventions

Botulinum Toxins, Type A (37)  ·  Deep Brain Stimulation (22)  ·  abobotulinumtoxinA (14)  ·  Transcranial Magnetic Stimulation (12)  ·  Botulinum Toxins (10)  ·  incobotulinumtoxinA (7)  ·  Injections (4)  ·  Blood Specimen Collection (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Saline Solution (3)  ·  Trihexyphenidyl (3)  ·  rimabotulinumtoxinB (3)  ·  valbenazine (3)  ·  Control Groups (2)  ·  Exercise Test (2)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (35)  ·  University of Florida (17)  ·  Ipsen (11)  ·  Allergan (9)  ·  University Health Network, Toronto (7)  ·  University of Minnesota (6)  ·  Fondation Ophtalmologique Adolphe de Rothschild (5)  ·  University of California, San Francisco (5)  ·  University of Southern California (5)  ·  Emory University (4)  ·  Institut National de la Santé Et de la Recherche Médicale, France (4)  ·  Mayo Clinic (4)  ·  University of Texas Southwestern Medical Center (4)  ·  Vanderbilt University Medical Center (4)  ·  Western University, Canada (4)

Countries

United States (158)  ·  France (37)  ·  Germany (31)  ·  Canada (26)  ·  United Kingdom (20)  ·  Italy (17)  ·  Austria (13)  ·  Poland (10)  ·  Spain (10)  ·  Australia (9)  ·  China (9)  ·  Turkey (Türkiye) (9)  ·  Israel (7)  ·  Russia (7)  ·  Czechia (6)

Top investigators

Mark Hallett, M.D. (10)  ·  Kristina Simonyan, MD, PhD (5)  ·  Aparna Wagle Shukla, MD (3)  ·  Mandar Jog, MD (3)  ·  Akira Endo (2)  ·  Aparna Wagle Shukla, M.D. (2)  ·  David Vaillancourt, PhD (2)  ·  Debra J Ehrlich, M.D. (2)  ·  Emmanuel Flamand-Roze, MD, PhD (2)  ·  H. A. Jinnah, MD, PhD (2)  ·  Joseph Jankovic (2)  ·  Kendall Lee, MD, PhD (2)

Results publications

PMID 19191832, PMID 20359934, PMID 25324317, PMID 26679193, PMID 27939583, PMID 28674168, PMID 34316644, PMID 12566335, PMID 15689584, PMID 16206144, PMID 17093249, PMID 17905796, PMID 18439222, PMID 20801261, PMID 20841416, PMID 21312284, PMID 21386109, PMID 21553081, PMID 21764407, PMID 22021883, PMID 22054223, PMID 22398268, PMID 22550086, PMID 22924536, PMID 23123071, PMID 23604344, PMID 23687362, PMID 23779062, PMID 23801734, PMID 23861342, PMID 24396131, PMID 24436111, PMID 24440061, PMID 24828895, PMID 24951081, PMID 25084088, PMID 25127231, PMID 25168295, PMID 25175271, PMID 25476727, PMID 25524875, PMID 25595221, PMID 25673742, PMID 25823758, PMID 25923718, PMID 25929664, PMID 26046412, PMID 26074391, PMID 26204475, PMID 26495947

NIH funding

U54NS065701 (3), 2005 (2), U54TR001456 (2), 2004 (1), 2015 (1), 2016 (1), K23NS149280 (1), KL2TR000065 (1), R01DC011805 (1), R01DC012545 (1), R01DC016315 (1), R01DE030464 (1), R01EB006136 (1), R01HD112563 (1), R01NS058487 (1)